124 Recruiting Hepatocellular Carcinoma Clinical Trials
Explore open interventional and observational research studies actively enrolling participants across the USA. Verify eligibility and contact site coordinators directly.
📍 Find Near Me by DistanceBrowse by State
Browse by Study Phase
Top Interventions for Hepatocellular Carcinoma
Related Conditions
Top Recruiting Hepatocellular Carcinoma Studies
TACE With or Without SBRT as Bridging Therapy for Pre-transplant HCC Patients
📍 Loyola University Medical Center — Maywood, Illinois
View Study & Checklist ➔Cryoablation and Arterial Infusion of SD-101 in Combination With Durvalumab and Tremelimumab
📍 University of California, San Diego — San Diego, California
View Study & Checklist ➔Feasibility and Efficacy of Perioperative Nivolumab With or Without Relatlimab for Patients With Potentially Resectable Hepatocellular Carcinoma (HCC)
📍 Sidney Kimmel Comprehensive Cancer Center — Baltimore, Maryland
View Study & Checklist ➔TheraSphere With Durvalumab and Tremelimumab for HCC
📍 University of California San Diego — San Diego, California
View Study & Checklist ➔Blood Salvage in Orthotopic Liver Transplantation With HCC
📍 University Health Network — Toronto, Ontario
View Study & Checklist ➔Study to Evaluate Adverse Events, and Change in Disease Activity, When Intravenously (IV) Infused With Livmoniplimab in Combination With IV Infused Budigalimab in Adult Participants With Hepatocellular Carcinoma (HCC)
📍 Arizona Oncology Associates, PC - NAHOA Prescott Valley /ID# 254313 — Prescott Valley, Arizona
View Study & Checklist ➔Role of Lisinopril in Preventing the Progression of Non-Alcoholic Fatty Liver Disease, RELIEF-NAFLD Study
📍 Cedars Sinai Medical Center — Los Angeles, California
View Study & Checklist ➔A Study of Nivolumab in Participants With Hepatocellular Carcinoma Who Are at High Risk of Recurrence After Curative Hepatic Resection or Ablation
📍 Local Institution - 0081 — Anniston, Alabama
View Study & Checklist ➔A Global Study to Evaluate Transarterial Chemoembolization (TACE) in Combination With Durvalumab and Bevacizumab Therapy in Patients With Locoregional Hepatocellular Carcinoma
📍 Research Site — Costa Mesa, California
View Study & Checklist ➔Contrast-enhanced MRI in Detecting Benign and Malignant Liver Lesions
📍 M D Anderson Cancer Center — Houston, Texas
View Study & Checklist ➔An Exploratory Study of Atezolizumab and Bevacizumab in Hepatocellular Carcinoma and Non-Small Cell Lung Cancer With Liver Metastases (INTEGRATE)
📍 Princess Margaret Cancer Centre — Toronto, Ontario
View Study & Checklist ➔A Study of Nofazinlimab (CS1003) in Subjects With Advanced Hepatocellular Carcinoma
📍 Southern California Research Center — Coronado, California
View Study & Checklist ➔Study of Durvalumab and Tremelimumab as First-line Treatment in Patients With Advanced Hepatocellular Carcinoma
📍 Research Site — Los Angeles, California
View Study & Checklist ➔Assess Efficacy and Safety of Durvalumab Alone or Combined With Bevacizumab in High Risk of Recurrence HCC Patients After Curative Treatment
📍 Research Site — Birmingham, Alabama
View Study & Checklist ➔A Study of Durvalumab or Tremelimumab Monotherapy, or Durvalumab in Combination With Tremelimumab or Bevacizumab in Advanced Hepatocellular Carcinoma
📍 Research Site — Phoenix, Arizona
View Study & Checklist ➔SBRT + Atezolizumab + Bevacizumab in Resectable HCC
📍 Massachusetts General Hospital Cancer Center — Boston, Massachusetts
View Study & Checklist ➔A Phase I/II Study to Evaluate AZD5851 in GPC3+ Advanced/Recurrent Hepatocellular Carcinoma
📍 Research Site — Phoenix, Arizona
View Study & Checklist ➔Study of Novel Immunomodulators as Monotherapy and in Combination With Anticancer Agents in Participants With Advanced Hepatobiliary Cancer
📍 Research Site — Birmingham, Alabama
View Study & Checklist ➔A Trial of Casdozokitug in Combination With Toripalimab Plus Bevacizumab in Participants With Unresectable and/or Locally Advanced or Metastatic Hepatocellular Carcinoma
📍 Mayo Clinic - Scottsdale — Scottsdale, Arizona
View Study & Checklist ➔Radioembolization Trial Utilizing Eye90 Microspheres™ for the Treatment of Hepatocellular Carcinoma (HCC)
📍 The University of Arizona Cancer Center — Tucson, Arizona
View Study & Checklist ➔Lipiodol Deposition Using Endhole vs. Pressure-Modulated Delivery
📍 Abramson Cancer Center of the University of Pennsylvania — Philadelphia, Pennsylvania
View Study & Checklist ➔A Study Evaluating Atezolizumab, With or Without Bevacizumab, in Participants With Unresectable Hepatocellular Carcinoma and Child-pugh B7 and B8 Cirrhosis
📍 University of Arizona Cancer Center — Tucson, Arizona
View Study & Checklist ➔Registry 17-009: Multi-Institutional Study Examining Patients With HCC Undergoing Liver Transplantation
📍 Cleveland Clinic Foundation — Cleveland, Ohio
View Study & Checklist ➔ALTUS: Performance of a Multi- Target Hepatocellular Carcinoma (HCC) Test in Subjects With Increased Risk
📍 Arizona Health Research — Chandler, Arizona
View Study & Checklist ➔Sorafenib Plus Doxorubicin in Patients With Advanced Hepatocellular Carcinoma With Disease Progression on Sorafenib
📍 Memorial Sloan Kettering Cancer Center at Basking Ridge — Basking Ridge, New Jersey
View Study & Checklist ➔A Study Evaluating Atezolizumab and Bevacizumab, With or Without Tiragolumab, in Participants With Untreated Locally Advanced or Metastatic Hepatocellular Carcinoma (HCC) (IMbrave152)
📍 Genesis Cancer Center — Hot Springs, Arkansas
View Study & Checklist ➔BOXR1030 T Cells in Subjects With Advanced GPC3-Positive Solid Tumors
📍 Hoag Hospital Newport Beach — Newport Beach, California
View Study & Checklist ➔Evaluate Durvalumab and Tremelimumab +/- Lenvatinib in Combination With TACE in Patients With Locoregional HCC
📍 Research Site — Birmingham, Alabama
View Study & Checklist ➔Study of Cabozantinib in Combination With Atezolizumab Versus Sorafenib in Participants With Advanced Hepatocellular Carcinoma (HCC) Who Have Not Received Previous Systemic Anticancer Therapy
📍 Exelixis Clinical Site #208 — Phoenix, Arizona
View Study & Checklist ➔Durvalumab (MEDI4736) and Tremelimumab and Radiation Therapy in Hepatocellular Carcinoma and Biliary Tract Cancer
📍 Massachusetts General Hospital — Boston, Massachusetts
View Study & Checklist ➔LTFU for All Cell and Gene Therapy Studies
📍 Research Site — Phoenix, Arizona
View Study & Checklist ➔Yttrium-90 Radiation Segmentectomy for Hepatocellular Carcinoma
📍 University of California, San Francisco — San Francisco, California
View Study & Checklist ➔Scheduled Meditation for Improving Postoperative Outcomes in Patients Undergoing Pancreatectomy
📍 City of Hope Medical Center — Duarte, California
View Study & Checklist ➔Cemiplimab +/- Fianlimab Post Y90 Radioembolization in Patients With Hepatocellular Carcinoma
📍 Virginia Commonwealth University — Richmond, Virginia
View Study & Checklist ➔Maintenance Zanzalintinib and Durvalumab in Participants With Advanced Hepatocellular Cancer
📍 University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center — Cleveland, Ohio
View Study & Checklist ➔Atezolizumab and Bevacizumab in Combination With Y^90 Radioembolization in HCC for Liver Transplant
📍 Icahn School of Medicine at Mount Sinai — New York, New York
View Study & Checklist ➔A Study to Assess the Dose, Adverse Events, and Change in Disease Activity of Livmoniplimab as an Intravenous (IV) Solution in Combination With Budigalimab as an IV Solution in Adult Participants With Hepatocellular Carcinoma (HCC)
📍 City of Hope /ID# 261468 — Duarte, California
View Study & Checklist ➔Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer
📍 Stanford University — Palo Alto, California
View Study & Checklist ➔A Trial Utilizing 18F-FS PG PET to Guide Therapy in Hepatocellular Carcinoma
📍 The University of Texas M. D. Anderson Cancer Center — Houston, Texas
View Study & Checklist ➔Combination of TATE and PD-1 Inhibitor in Liver Cancer
📍 University of California, Irvine — Orange, California
View Study & Checklist ➔